STATE OF WISCONSIN INVESTMENT BOARD - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 193 filers reported holding NEKTAR THERAPEUTICS in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2023$16,699
-95.8%
23,757
-86.5%
0.00%
-100.0%
Q4 2022$398,872
-33.6%
176,492
-6.0%
0.00%
-50.0%
Q3 2022$601,000
-20.0%
187,822
-5.0%
0.00%0.0%
Q2 2022$751,000
-16.2%
197,620
+18.9%
0.00%0.0%
Q1 2022$896,000
+201.7%
166,244
+655.1%
0.00%
+100.0%
Q4 2021$297,000
-25.6%
22,016
-1.0%
0.00%0.0%
Q3 2021$399,000
+9.6%
22,242
+5.0%
0.00%0.0%
Q2 2021$364,000
-17.3%
21,191
-3.6%
0.00%0.0%
Q1 2021$440,000
+16.1%
21,978
-1.4%
0.00%0.0%
Q4 2020$379,000
-1.6%
22,289
-4.0%
0.00%0.0%
Q3 2020$385,000
-27.1%
23,229
+2.0%
0.00%0.0%
Q2 2020$528,000
-78.6%
22,779
-83.5%
0.00%
-87.5%
Q1 2020$2,470,000
-18.0%
138,350
-0.9%
0.01%0.0%
Q4 2019$3,012,000
-17.0%
139,540
-30.0%
0.01%
-20.0%
Q3 2019$3,631,000
-45.3%
199,366
+6.8%
0.01%
-47.4%
Q2 2019$6,643,000
+69.5%
186,699
+60.0%
0.02%
+72.7%
Q1 2019$3,920,000
-50.0%
116,662
-51.1%
0.01%
-57.7%
Q4 2018$7,843,000
-42.1%
238,612
+7.5%
0.03%
-29.7%
Q3 2018$13,536,000
+85.0%
222,056
+48.2%
0.04%
+76.2%
Q2 2018$7,318,000
-56.1%
149,860
-4.5%
0.02%
-56.2%
Q1 2018$16,683,000
+90.0%
157,000
+6.8%
0.05%
+100.0%
Q4 2017$8,779,000
+218.1%
147,000
+27.8%
0.02%
+200.0%
Q3 2017$2,760,000
+22.8%
115,0000.0%0.01%
+14.3%
Q2 2017$2,248,000115,0000.01%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2023
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 508,000$6,132,0001.80%
Bodri Capital Management, LLC 250,000$3,018,0001.46%
Granahan Investment Management 3,442,980$41,557,0001.28%
TIRSCHWELL & LOEWY INC 603,441$7,284,0001.22%
NEA Management Company, LLC 1,825,600$22,035,0001.12%
Cormorant Asset Management, LP 450,000$5,432,0001.12%
HARVEY CAPITAL MANAGEMENT INC 221,750$2,676,0001.05%
Cheyne Capital Management (UK) LLP 229,577$2,772,0000.99%
Artal Group S.A. 1,650,000$19,916,0000.73%
FIC CAPITAL INC 147,293$1,778,0000.71%
View complete list of NEKTAR THERAPEUTICS shareholders